What exactly do double-chin injections target?
A double chin describes visible fullness beneath the chin, but that shape is not always caused by a layer of superficial fat alone. Loose skin, jaw structure, platysmal bands, a prominent salivary gland, thyroid enlargement or a neck mass can produce a similar outline. Official deoxycholic-acid prescribing information directs the healthcare professional to examine other causes of submental fullness before treatment and to assess the skin, tissues and surrounding anatomy. If the main cause is not subcutaneous fat, a fat-dissolving injection will not correct the underlying problem [1, 9].
The regulated use is to improve the appearance of moderate or severe fullness associated with submental fat in adults. “Improve” matters: treatment does not promise to remove a double chin completely, is not a way to lower body weight and is not a substitute for obesity care. It is a limited cosmetic intervention for a small area in an appropriately selected person after direct examination. Trials assessed changes in fullness as judged by clinicians and participants, with some studies also using imaging measures; their outcome was a better contour, not a number on the scale [1, 3, 4, 5].
The decision therefore should not begin with a before-and-after photograph or a home pinch test. It begins by identifying the tissue responsible for the contour. Is there a definable superficial fat layer? Does the skin have suitable elasticity? Is there pre-existing asymmetry or weakness around the mouth that should be documented before injection? Is the expected change modest and realistic? Practice reviews emphasize that patient selection and knowledge of submental anatomy are central to both outcome and safety, not administrative steps before a session [8, 9].
Deoxycholic acid: what approval does and does not mean
Deoxycholic acid is the active ingredient studied in the product approved by the US Food and Drug Administration to improve moderate or severe fullness associated with submental fat in adults. The prescribing information describes it as a cytolytic medicine that physically disrupts cell membranes when injected into tissue, producing cell breakdown at the injection site. That property is why it must be placed accurately within the target fat; exposure of unintended tissue can cause injury [1, 11].
US approval does not extend to the abdomen, arms, thighs or any area outside submental fat. The current official label states that the medicine is not approved for subcutaneous fat outside this region and that such use is not recommended. Approval of one defined substance, concentration and method also does not transfer automatically to every mixture marketed as “mesotherapy” or “fat dissolving.” The FDA has warned about unapproved products and self-injection after reports including infection, scarring, deformity and painful knots [1, 2].
A familiar brand name in a search result does not prove that an offered vial is authentic or locally registered, and it does not show that treatment is suitable for you. Ask for the generic ingredient, concentration, manufacturer, lot number, local authorization status and the qualification of the person injecting it. This article describes evidence for submental deoxycholic acid only and does not imply that La Rose uses any particular brand. If the substance or vial cannot be identified, results from published trials cannot reasonably be transferred to it [1, 5, 8].
What does the evidence say about results?
Randomized trials compared deoxycholic acid with placebo injections in adults with submental fat. European phase 3 studies found greater improvement in fullness ratings with active treatment than with placebo, using both clinician and participant assessments. A pooled analysis used treatments separated by approximately four weeks and assessed outcomes after a defined follow-up period, so the evidence was not based on judging appearance during the first days of swelling [3, 4].
A systematic review and meta-analysis of randomized trials reached the same broad direction: deoxycholic acid was more effective than placebo for reducing submental fat on the measures used. However, the review rated the certainty of evidence as low to moderate and highlighted industry sponsorship across the included trials. This means there is evidence of improvement in a selected population, but it should be presented calmly rather than turning trial averages into an individual promise [5, 8].
Response varies between people, and the result is not immediate. Early swelling may temporarily make the area look larger, while trial outcomes were assessed after treatment and follow-up rather than the following day. A later study followed responders from the REFINE trials for up to three years and examined durability, but it enrolled people who had already achieved improvement. It therefore cannot guarantee a lasting response for everyone who begins treatment [6, 7].
Standardized photographs plus clinician- and patient-rated fullness are reasonable ways to follow progress. Body weight and waist circumference are not appropriate success measures for a small intervention beneath the chin. Before starting, agree what degree of change would be worthwhile, when it will be assessed and when to stop if improvement is insufficient or reactions are unacceptable. A realistic expectation is a variable improvement in contour, not perfect features or a guaranteed result [5, 8].
How many treatments? The label gives a maximum, not a fixed plan
The current US label permits up to six separate treatments, with no less than one month between treatments. During one treatment, the dose is distributed across points within submental fat. The label specifies 0.2 mL per injection spaced one centimetre apart, with a maximum of 50 injections and 10 mL in a single treatment. These are upper limits for labeled administration, not numbers that every person must reach [1].
The actual plan follows mapping of the area and assessment of fat volume, anatomy and response to the previous treatment. A clinician may use fewer points because the treatment area is smaller, and treatment may stop before the maximum when the agreed improvement has been reached or when continuing is unsuitable. “Up to six” should not become a compulsory package, and more injections or a shorter interval should not be assumed to produce a faster result. An individual prescription remains the decision of a qualified healthcare professional within the local label [1, 4, 8].
Every visit should start by reviewing what happened after the preceding treatment: the degree of swelling and pain, numbness or firmness, any difficulty swallowing, a change in the smile, a persistent lump or a skin problem. Photographs should also be compared with consistent lighting and position rather than relying on a shifting impression. If tissue is still inflamed or a symptom needs diagnosis, assessment takes priority over automatically proceeding to the next treatment. The label's minimum interval does not replace clinical judgment [1, 9].
Do not attempt to divide a vial, alter its concentration or reinject yourself, and do not buy the substance online. Safe treatment depends on the correct dose, position and depth of every injection and avoidance of the nerve, muscle, glands and blood vessels. A best-practice review treats anatomical planning and injection technique as essential parts of treatment, not optional details [2, 8].
Swelling, pain and numbness: what is expected?
In controlled trials, the most common reactions were swelling, bruising, pain, numbness, redness and firmness in the treatment area. Most events in phase 3 studies were associated with the injection site, and many were temporary and mild or moderate. That does not make every degree or direction of pain and swelling normal. You should receive written instructions describing the expected course for the product used and whom to contact if your course differs [1, 3, 4, 6].
Swelling can temporarily alter the chin's appearance, so early photographs cannot judge the result. Numbness, tenderness or a firm feeling may occur in the treated area. An expected reaction tends to improve; a symptom that worsens, occurs with fever, discharge or a marked skin-colour change, or includes an enlarging lump needs review. Do not massage a lump forcefully or add a topical product or medicine yourself because the procedure was cosmetic [1, 9, 12].
Plan practically for the possibility of visible swelling and bruising. A 12-month open-label study recorded that some participants missed work or social activity after treatment, illustrating that “nonsurgical” does not mean there can be no recovery time or visible effect. Disruption varies, so ask about the usual experience with the exact product rather than relying on advertising that promises an immediate return to every activity [6].
The purpose is neither to frighten you about an expected local reaction nor to give blanket reassurance. Direction and context matter: familiar swelling that is improving with normal breathing and swallowing differs from rapid swelling in the mouth or neck; a stable bruise differs from skin that blanches, darkens or ulcerates. A contact number and follow-up plan are part of informed consent before the first injection [1, 9].
Signs that need prompt contact or urgent care
Injury to the marginal mandibular nerve branch is a specific labeled risk and can appear as an uneven smile or weakness of the lower facial muscles. Any new asymmetry after injection needs prompt contact with the healthcare professional, documentation and examination, not another treatment intended to conceal it. Published reviews of complications also discuss nerve injuries and difficulty swallowing and emphasize early recognition and a management plan [1, 9].
New difficulty swallowing must be taken seriously. The label includes it among the risks and cautions that people with current or previous dysphagia may be more susceptible. Seek urgent care if swallowing difficulty prevents fluids, or if there is breathing difficulty or rapid swelling of the tongue or throat. These are not symptoms to leave until a routine cosmetic follow-up [1, 9].
Superficial injection or placement outside the target fat can cause ulceration, necrosis and infection. Request prompt assessment for severe or increasing pain, pale skin or purple or dark discoloration, blisters or an open wound, spreading redness and heat, discharge or fever. The official update also warns about injection-site nodules or masses that may not resolve and may require medical intervention. Analyses of reports cannot establish a precise incidence, but they show the kinds of problems that should not be ignored [1, 2, 10, 12].
Infection at the injection site is a clear labeled contraindication. Also disclose bleeding problems and every medicine and supplement, particularly antiplatelet or anticoagulant treatment. Do not stop a prescribed medicine yourself; the prescriber and treating professional should decide the plan. Mention previous surgery, liposuction, threads or injections around the neck because scarring and altered landmarks may make safe placement more difficult [1, 8].
The next step: a calm decision after direct assessment
Before the visit, write your goal in one simple sentence and bring a list of medicines, allergies and previous facial or neck procedures. If a product has been proposed, obtain its generic name plus a clear photograph of the vial and lot number. Ask about the alternative of no treatment and about different options when loose skin or jaw structure, rather than fat, is responsible. Nonsurgical contouring includes several approaches, but each targets different tissue and carries different risks; no single procedure has to suit everyone [1, 8].
During assessment, the cause of fullness should be identified and the pre-treatment smile and skin documented. Discuss the number of treatments as an adjustable possibility, not an advance commitment, and ask when improvement will be measured and what would stop the plan. Review common reactions, important warning signs and the contact route if a symptom develops. If assessment concludes that fat is not the main cause or the risks outweigh the expected change, not injecting is a sound medical outcome, not a failure [1, 8, 9].
The medical team at La Rose can begin with a structured assessment without promising an outcome or assuming that you need injections. La Rose has branches in Maadi and Fifth Settlement, New Cairo. This article does not state that the clinic uses a specific brand; suitability for any procedure and the substance used remain decisions for the treating clinician after examination and review of the available product [1, 5].
If you want to discuss fullness beneath the chin, book a consultation and note that your question concerns submental fat, any substance offered to you and any current symptoms. If you have breathing difficulty, swallowing difficulty that prevents fluids, rapid mouth or neck swelling, or a severe skin change after a previous injection, do not wait for a routine appointment; seek appropriate urgent care [1, 10].
